Cargando…

Lack of health maintenance examinations and risk in myeloma patients

Health maintenance (HM) practices are essential to prevent illness, promote well‐being, and maximize health. Patients with multiple myeloma (MM) are at increased risk for cardiovascular disease and cancers, yet, research on HM practices and preventative care of MM survivors has limited report. The s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tariman, Joseph D., Gleason, Charise, Faiman, Beth, Doss, Deborah, Catamero, Donna, Bishop‐Royse, Jessica, Katz, Mike, Kurtin, Sandra, Moran, Diane, Lonial, Sagar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944868/ https://www.ncbi.nlm.nih.gov/pubmed/27119422 http://dx.doi.org/10.1002/cam4.716

Ejemplares similares

A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
por: Catamero, Donna, et al.
Publicado: (2022)

Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib
por: Nooka, Ajay, et al.
Publicado: (2013)

New Treatment Strategies Making an Impact in Multiple Myeloma
por: Gleason, Charise, et al.
Publicado: (2017)

Novel Treatments for Patients With Relapsed/Refractory Multiple Myeloma
por: Rodriguez, Cesar, et al.
Publicado: (2023)

Validation of Self-Reported Caprini Risk Assessment Score to Empower Urdu Speakers
por: Lalani, Khairunisa, et al.
Publicado: (2023)

Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
por: Kaufman, Jonathan L., et al.
Publicado: (2019)

Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
por: Faiman, Beth, et al.
Publicado: (2023)

Innovative Agents in Multiple Myeloma
por: Faiman, Beth, et al.
Publicado: (2014)

A Focus on Relapsed Multiple Myeloma
por: Noonan, Kimberly, et al.
Publicado: (2022)

Role competency scale on shared decision-making nurses: Development and psychometric properties
por: Tariman, Joseph D, et al.
Publicado: (2018)

A Focus on Newly Diagnosed Multiple Myeloma
por: Brigle, Kevin, et al.
Publicado: (2022)

Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes
por: Faiman, Beth, et al.
Publicado: (2016)

A Focus on Special Populations in Relapsed Multiple Myeloma
por: Steinbach, Mary, et al.
Publicado: (2022)

Smoldering multiple myeloma current treatment algorithms
por: Rajkumar, S. Vincent, et al.
Publicado: (2022)

Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma
por: Ackley, James, et al.
Publicado: (2021)

Acute FPIES and DIES: is a G lacking?
por: Novembre, Elio, et al.
Publicado: (2023)

Top Information Need Priorities of Older Adults Newly Diagnosed With Active Myeloma
por: Tariman1, Joseph D., et al.
Publicado: (2015)

Implications of ubiquitination and the maintenance of replication fork stability in cancer therapy
por: Xia, Donghui, et al.
Publicado: (2023)

Nurse Self-Evaluation of Assessment of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
por: Visovsky, Constance, et al.
Publicado: (2012)

NS-64: Lessons learned: patient management and outcomes of Multiple Myeloma patients during the COVID-19 pandemic in New York City
por: Catamero, Donna, et al.
Publicado: (2021)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
por: McGrath, Leah J., et al.
Publicado: (2018)

Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor
por: Joseph, Nisha S, et al.
Publicado: (2021)

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
por: Kumar, Shaji K., et al.
Publicado: (2019)

Integrating Emerging Data Into Clinical Practice: A Case-Based Approach for Multiple Myeloma
por: Kurtin, Sandra
Publicado: (2017)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
por: Chakraborty, Rajshekhar, et al.
Publicado: (2021)

Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo
por: Tandon, Vasudha, et al.
Publicado: (2022)

Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials
por: Shao, Fengping, et al.
Publicado: (2020)

Non-invasive detection of corneal sub-basal nerve plexus changes in multiple myeloma patients by confocal laser scanning microscopy
por: Koschmieder, Anita, et al.
Publicado: (2020)

Association of response endpoints with survival outcomes in multiple myeloma
por: Lonial, S, et al.
Publicado: (2014)

Novel Agents for the Treatment of Multiple Myeloma: Proteasome Inhibitors and Immunomodulatory Agents
por: Kurtin, Sandra E., et al.
Publicado: (2013)

Extrapyramidal Symptoms with Administration of Lenalidomide Maintenance Therapy for Multiple Myeloma
por: Sagar, FNU, et al.
Publicado: (2018)

Lack of association between miR-146a rs2910164 C/G locus and colorectal cancer: from a case–control study to a meta-analysis
por: Jiang, Jiakai, et al.
Publicado: (2021)

MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma
por: Wang, Dongxue, et al.
Publicado: (2017)

Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
por: Radocha, Jakub, et al.
Publicado: (2018)

Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial‐ethnic group, United States 2003‐2016
por: Ellington, Taylor D., et al.
Publicado: (2020)

Epidemiology of multiple myeloma in 17 Latin American countries: an update
por: Curado, Maria Paula, et al.
Publicado: (2018)

Maintenance therapy in multiple myeloma
por: Harousseau, Jean-Luc
Publicado: (2009)

Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma
por: Chaulagain, Chakra P, et al.
Publicado: (2022)

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
por: Suzuki, Kazuhito, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0g2bvbuug8svlkqlo10iho82m3